Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Marsha A. Ketcham"'
3
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Autor: Surinder K. Batra, Anne Kessinger, Vinicius Ernani, Imayavaramban Lakshmanan, Jolene Tijerina, Maneesh Jain, Mohd W. Nasser, Lynette M. Smith, Rahat Jahan, Sarah E. Kimbrough, Shannon Pivovar, Mary E. Kos, Kavita Mallya, Apar Kishor Ganti, Sanchita Rauth, Alissa S. Marr, Marsha A. Ketcham
Publikováno v: Cancer Treatment and Research Communications, Vol 22, Iss, Pp 100162-(2020)
Cancer Treat Res Commun
Background Relapsed/refractory small cell lung cancer (SCLC) has a poor prognosis, with no good options. We evaluated a novel combination of topotecan and doxorubicin, providing sequential topoisomerase I and II inhibition, in this setting. Materials
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5feb21655985c7b2c3a4d2f048872752
http://www.sciencedirect.com/science/article/pii/S2468294219301583
Zobrazit plný text záznamu
4
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Autor: Marsha A. Ketcham, Alissa S. Marr, Anne Kessinger, Mary M. Huerter, Addison Tolentino, Karin Swenson, Holly DeSpiegelaere, Jane L. Meza, M. Sitki Copur, Apar Kishor Ganti, Susan Kruse, Mary E. Kos, Sarah E. Radniecki
Publikováno v: Journal of Geriatric Oncology. 8:18-22
Objective Platinum-based doublet chemotherapy is the standard for most patients with advanced non-small cell lung cancer (NSCLC). Toxicity concerns limit chemotherapy for patients over 70 years. Vinorelbine and paclitaxel are effective as single agen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2441ff06c523c7eb4fb23b557e82509
https://doi.org/10.1016/j.jgo.2016.07.006
Zobrazit plný text záznamu
6
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study
Autor: Caitlyn M. Plonka, Randall E. Brand, Daniel P. Normolle, Oleg Shats, Michelle A. Anderson, Wendy S. Rubinstein, Amy N. Mertens, Kristine L. Cooper, Paola Ghiorzo, William E. Grizzle, Kristen J. Vogel, Shih Yuan Lee, Henry T. Lynch, David C. Whitcomb, Aaron R. Sasson, Marsha A. Ketcham, Renee C. Tripon, Simon Sherman, Eugene Zolotarevsky
Publikováno v: The American journal of gastroenterology. 107(11)
The objective of this study was to examine the association between tobacco and alcohol dose and type and the age of onset of pancreatic adenocarcinoma (PancCa).Prospective data from the Pancreatic Cancer Collaborative Registry were used to examine th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c0463ecdf37d01646a8ea8498c89f7
https://pubmed.ncbi.nlm.nih.gov/22929760
Zobrazit plný text záznamu
8
Survival outcome of a phase I trial: Hypofractionated stereotactic body radiation therapy concurrent with nelfinavir following gemcitabine and 5FU in patients with locally advanced pancreatic adenocarcinoma
Autor: Quan P. Ly, Chi Lin, Chandrakanth Are, Audrey J. Lazenby, Aaron R. Sasson, Jean L. Grem, James K. Schwarz, Eugene D Sehi, Marsha A. Ketcham, Beth M Kos
Publikováno v: Journal of Clinical Oncology. 32:284-284
284 Background: We analyzed overall survival (OS) of patients enrolled in a phase I trial of hypo-fractionated stereotactic body radiation therapy (HFSBRT) concurrent with nelfinavir as part of neoadjuvant chemoradiation regimen in patients with bord
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::310048f7402dc345956231e54a937c23
https://doi.org/10.1200/jco.2014.32.3_suppl.284
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje